2012Guoji yiyao weisheng daobaoRequires access

Desloratadine for chronic urticaria

Ya-sheng Yang

Open publisher page 0 citations

Abstract

Objective To investigate the efficacy and safety of desloratadine in the treatment of chronic urticaria.Methods Nity-two adult patients with chronic urticaria were randomly divided into study group and control group,46 for each group.The study group received 10 mg desloratadine orally once daily for 28 days,while the control group received cetirizin orally.The efficacy was assessed by the total scores for symptoms and signs.Results 28 days after treatment,the cure rate was 82.61% and the total effectiveness rate was 95.65% in the study group; and they were 60.87% and 80.43% in the control group,respectively.The efficacy differed significantly between the two groups ( Uc =6.0922,P=0.0136 ).Hypersomnia occurred in one patient in the study group but in sixteen patients in the control group.There were significant differences in adverse reactions between the two groups ( x2=14.5607,P < 0.01 ).Conclusions Desloratadine is effective and safe in the treatment of chronic urticaria. Key words: Desloratadine; Chronic urticaria; Cetirizine

About this research paper

What this paper is about

Objective To investigate the efficacy and safety of desloratadine in the treatment of chronic urticaria.Methods Nity-two adult patients with chronic urticaria were randomly divided into study group and control group,46 for each group.The study group received 10 mg desloratadine orally once daily for 28 days,while the control group received cetirizin orally.The efficacy was assessed by the total scores for symptoms and signs.Results 28 days after treatment,the cure rate was 82.61% and the total effectiveness rate was 95.65% in the study group; and they were 60.87% and 80.43% in the control group,respectively.The efficacy differed significantly between the two groups ( Uc =6.0922,P=0.0136 ).Hypersomnia occurred in one patient in the study group but in sixteen patients in the control group.There were significant differences in adverse reactions between the two groups ( x2=14.5607,P < 0.01 ).Conclusions Desloratadine is effective and safe in the treatment of chronic urticaria. Key words: Desloratadine; Chronic urticaria; Cetirizine

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the efficacy and safety of desloratadine in the treatment of chronic urticaria.Methods Nity-two adult patients with chronic urticaria were randomly divided into study group and control group,46 for each group.The study group received 10 mg desloratadine orally once daily for 28 days,while the control group received cetirizin orally.The efficacy was assessed by the total scores for symptoms and signs.Results 28 days after treatment,the cure rate was 82.61% and the total effectiveness rate was 95.65% in the study group; and they were 60.87% and 80.43% in the control group,respectively.The efficacy differed significantly between the two groups ( Uc =6.0922,P=0.0136 ).Hypersomnia occurred in one patient in the study group but in sixteen patients in the control group.There were significant differences in adverse reactions between the two groups ( x2=14.5607,P < 0.01 ).Conclusions Desloratadine is effective and safe in the treatment of chronic urticaria. Key words: Desloratadine; Chronic urticaria; Cetirizine

Key concepts: Desloratadine, Medicine, Chronic urticaria, Cetirizine, Adverse effect, Clinical efficacy, Chronic idiopathic urticaria, Levocetirizine

Related papers

Back to paper searchBrowse research topicsOriginal source
Desloratadine for chronic urticaria — Research Paper | ScholarLens